VAERS reports by lot

Pfizer COVID-19 lot EN9809: VAERS reports

23 VAERS reports list lot EN9809 as a Pfizer COVID-19 vaccine, received between 2021-02-11 and 2022-06-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
22%
Marked serious
1
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2519%
Cardiac / Cardiovascular2216%
Neurological1511%
Respiratory1511%
Gastrointestinal1511%
Dermatological (non-injection-site)118%
Musculoskeletal97%
Injection-site / Local reaction97%
Allergic / Anaphylactic64%
Autoimmune / Immune-mediated32%
Psychiatric / Neuropsychiatric32%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Alabama3
California3
New York2
Massachusetts2
Ohio2
Indiana1
Minnesota1
Kansas1
Missouri1
Nebraska1
North Carolina1
Virginia1

Reports by month received

2021-025
2021-033
2021-041
2021-071
2021-082
2021-093
2021-102
2022-013
2022-032
2022-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.